ACTIMIS Trademark

Trademark Overview

On Wednesday, January 5, 2005, a trademark application was filed for ACTIMIS with the United States Patent and Trademark Office. The USPTO has given the ACTIMIS trademark a serial number of 78542796. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 6, 2018. This trademark is owned by Actimis Pharmaceuticals, Inc.. The ACTIMIS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research, technological and development services, namely, pharmaceutical research and pharmaceutical drug development services for applying proprietary chemical technologies and analysis to pharmaceutical drug discovery processes and research, identifying novel drug targets and biomarkers, selectively profiling drug candidates in biological samples, characterizing target activities of drug candidates and established drugs to understand the basis for their efficacy and toxicity, and monitoring clinical trials in the field of respiratory, anti-inflammatory and auto-immunity disorders; laboratory research in the field of respiratory, anti-inflammatory and auto-immunity disorders
actimis

General Information

Serial Number78542796
Word MarkACTIMIS
Filing DateWednesday, January 5, 2005
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 6, 2018
Registration Number3349432
Registration DateTuesday, December 4, 2007
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 11, 2006

Trademark Statements

Goods and ServicesScientific research, technological and development services, namely, pharmaceutical research and pharmaceutical drug development services for applying proprietary chemical technologies and analysis to pharmaceutical drug discovery processes and research, identifying novel drug targets and biomarkers, selectively profiling drug candidates in biological samples, characterizing target activities of drug candidates and established drugs to understand the basis for their efficacy and toxicity, and monitoring clinical trials in the field of respiratory, anti-inflammatory and auto-immunity disorders; laboratory research in the field of respiratory, anti-inflammatory and auto-immunity disorders

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 6, 2018
Primary Code042
First Use Anywhere DateFriday, December 31, 2004
First Use In Commerce DateFriday, December 31, 2004

Trademark Owner History

Party NameActimis Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameActimis Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameActimis Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLa Jolla, CA 92037

Trademark Events

Event DateEvent Description
Friday, July 6, 2018CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Sunday, December 4, 2016COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, December 12, 2013NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, December 12, 2013REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, December 2, 2013REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Thursday, December 12, 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, December 2, 2013TEAS SECTION 8 & 15 RECEIVED
Tuesday, October 15, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 4, 2007REGISTERED-PRINCIPAL REGISTER
Thursday, November 1, 2007LAW OFFICE REGISTRATION REVIEW COMPLETED
Thursday, November 1, 2007ASSIGNED TO LIE
Monday, October 1, 2007ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, August 28, 2007STATEMENT OF USE PROCESSING COMPLETE
Tuesday, August 28, 2007EXTENSION 2 GRANTED
Monday, July 2, 2007USE AMENDMENT FILED
Monday, July 2, 2007EXTENSION 2 FILED
Monday, July 2, 2007TEAS EXTENSION RECEIVED
Monday, July 2, 2007TEAS STATEMENT OF USE RECEIVED
Thursday, May 31, 2007APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, May 31, 2007TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 19, 2007EXTENSION 1 GRANTED
Wednesday, January 3, 2007EXTENSION 1 FILED
Wednesday, January 3, 2007TEAS EXTENSION RECEIVED
Tuesday, July 4, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 11, 2006PUBLISHED FOR OPPOSITION
Wednesday, March 22, 2006NOTICE OF PUBLICATION
Wednesday, February 22, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, February 17, 2006ASSIGNED TO LIE
Tuesday, February 14, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 14, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 6, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 6, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 5, 2005NON-FINAL ACTION E-MAILED
Friday, August 5, 2005NON-FINAL ACTION WRITTEN
Friday, August 5, 2005ASSIGNED TO EXAMINER
Tuesday, July 5, 2005TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sunday, January 16, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

actimis drug research pharmaceutical inflammatory field candidates auto anti respiratory immunity